Epcoritamab Monotherapy Demonstrates Deep and Durable Responses at 3-Year Follow-Up in Patients With Relapsed/Refractory Follicular Lymphoma


Por: Karimi, Y, Vitolo, U, Jurczak, W, Lugtenburg, P, Gyan, E, Chavez, J, Sureda, A, Christensen, JH, Tilly, H, Cordoba, R, Lewis, D, Hutchings, M, Clausen, MR, Sancho, JM, Cochrane, T, Leppä, S, Chamuleau, M, Thieblemont, C, Izutsu, K, Fukuhara, N, Caimi, P, Andreadis, C, Vose, J, Favaro, E, Patah, P, Geybels, M, Altintas, I, Morehouse, C and Linton, K

Publicada: 1 sep 2025
Resumen:


Filiaciones:
Karimi, Y:
 Univ Michigan, Div Hematol Oncol, Ann Arbor, MI USA

Vitolo, U:
 FPO IRCCS, Candiolo Canc Inst, Turin, Italy

Jurczak, W:
 Maria Sklodowska Curie Natl Res Inst Oncol, Krakow, Poland

Lugtenburg, P:
 Univ Med Ctr, Lunenburg Lymphoma Phase I II Consortium HOVON LLP, Erasmus MC Canc Inst, Rotterdam, Netherlands

Gyan, E:
 Ctr Hosp Univ Tours, Serv Hematol & Therapie Cellulaire, INSERM, CIC U1415, Tours, France

Chavez, J:
 H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

Sureda, A:
 Inst Catala Oncol LHospitalet, IDIBELL, Barcelona, Spain

 Univ Barcelona, Barcelona, Spain

Christensen, JH:
 Odense Univ Hosp, Odense, Denmark

Tilly, H:
 Univ Rouen, Ctr Henri Becquerel, Rouen, France

Cordoba, R:
 Fdn Jimenez Diaz Univ Hosp, Madrid, Spain

Lewis, D:
 Univ Hosp Plymouth NHS Trust, Derriford Hosp, Plymouth, England

Hutchings, M:
 Rigshosp, Copenhagen, Denmark

 Univ Copenhagen, Copenhagen, Denmark

Clausen, MR:
 Vejle Hosp, Vejle, Denmark

:
 ICO Hosp Germans Trias i Pujol, Catalan Inst Oncol ICO, Barcelona, Spain

Cochrane, T:
 Gold Coast Univ Hosp, Gold Coast, Australia

Leppä, S:
 Univ Helsinki, Helsinki, Finland

 Helsinki Univ Hosp, Comprehens Canc Ctr, Helsinki, Finland

Chamuleau, M:
 Vrije Univ Amsterdam, Lunenburg Lymphoma Phase I II Consortium HOVON LLP, Amsterdam UMC, Med Ctr, Amsterdam, Netherlands

Thieblemont, C:
 Univ Paris, Hop St Louis, Assistance Publ & Hop Paris APHP, Hematooncol, Paris, France

Izutsu, K:
 Natl Canc Ctr, Tokyo, Japan

Fukuhara, N:
 Tohoku Univ Hosp, Sendai, Japan

Caimi, P:
 Cleveland Clin, Taussig Canc Inst, Cleveland, OH USA

Andreadis, C:
 Univ Calif San Francisco, San Francisco, CA USA

Vose, J:
 Univ Nebraska Med Ctr, Omaha, NE USA

Favaro, E:
 Genmab, Plainsboro, NJ USA

Patah, P:
 AbbVie, N Chicago, IL USA

Geybels, M:
 Genmab, Copenhagen, Denmark

Altintas, I:
 Genmab, Utrecht, Netherlands

Morehouse, C:
 Univ Nebraska Med Ctr, Omaha, NE USA

Linton, K:
 Univ Manchester, Christie NHS Fdn Trust, Manchester Canc Res Ctr, Manchester, England

 Univ Manchester, Div Canc Sci, Manchester, England
ISSN: 21522650





Clinical Lymphoma Myeloma & Leukemia
Editorial
Cancer Media Group, 3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA, Estados Unidos America
Tipo de documento: Meeting Abstract
Volumen: 25 Número:
Páginas:
WOS Id: 001607063000073

MÉTRICAS